Skip to content

Cohort Study on Long-term Clinical Outcomes and Prediction of Complications in Portal Hypertension

Cohort Study on Long-term Clinical Outcomes and Prediction of Complications in Portal Hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105733
Enrollment
Unknown
Registered
2025-07-09
Start date
2025-07-11
Completion date
Unknown
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Portal hypertension

Interventions

Portal hypertension with liver cirrhosis group:NA
Portal hypertension without liver cirrhosis group:NA
Chronic liver diseases without portal hypertension group:NA

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed with portal hypertension or patients with chronic liver disease but without portal hypertension; 2. Aged 18 to 75 years.

Exclusion criteria

Exclusion criteria: 1. Severe chronic diseases involving vital organs such as cardiovascular, respiratory and renal systems, etc; 2. Liver failure; 3. Severe decompensated events of liver cirrhosis within one week before enrollment, such as massive gastrointestinal bleeding, hepatorenal syndrome, hepatopulmonary syndrome, spontaneous bacterial peritonitis, etc; 4. Malignancies; 5. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Complications (Variceal bleeding, hepatic encephalopathy, ascites, infection, portal thrombosis, etc.);

Secondary

MeasureTime frame
Death and liver transplantation;

Countries

China

Contacts

Public ContactHao Wu

West China Hospital, Sichuan University

594264513@qq.com+86 28 8542 3387

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026